Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Body size–guided dual therapy for Helicobacter pylori infection
ChiCTR2400089491Phase 4Not yet recruiting
- Sponsor
- Beijing Jishuitan Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vonoprazan and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoint: Eradication rate of Helicobacter pylori. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
vonoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400089491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089491.